首页 | 本学科首页   官方微博 | 高级检索  
     

四味降脂胶囊治疗高脂血症的临床观察
引用本文:毛讯. 四味降脂胶囊治疗高脂血症的临床观察[J]. 中国药房, 2010, 0(28): 2654-2655
作者姓名:毛讯
作者单位:[1]郑州大学基础医学院,郑州市450000 [2]河南漯河医学高等专科学校,漯河市462000
摘    要:目的:观察四味降脂胶囊对高脂血症患者的疗效及对血清高敏C-反应蛋白(Hs-CRP)的影响。方法:86例高脂血症患者随机分为治疗组和对照组各43例,治疗组给予口服四味降脂胶囊,对照组给予口服阿托伐他汀,连续服药8周。检测用药前、后患者血清血脂和Hs-CRP水平。结果:2组患者治疗后Hs-CRP及血脂水平均明显低于治疗前(P<0.05),2组降幅及疗效比较无显著性差异(P>0.05)。2组不良反应均轻微,差异不明显。结论:四味降脂胶囊能降低高脂血症患者血脂及Hs-CRP水平,疗效与阿托伐他汀相当。

关 键 词:高脂血症  四味降脂胶囊  阿托伐他汀  高清C-反应蛋白

Clinical Observation of Siwei Jiangzhi Capsules in the Treatment of Hyperlipidemia
MAO Xun. Clinical Observation of Siwei Jiangzhi Capsules in the Treatment of Hyperlipidemia[J]. China Pharmacy, 2010, 0(28): 2654-2655
Authors:MAO Xun
Affiliation:MAO Xun(School of Preclinical Medical Sciences,Zhengzhou University,Zhengzhou 450000,China) MAO Xun(Luohe Medical College,Luohe 462000,China)
Abstract:OBJECTIVE:To study the clinical efficacy of Siwei jiangzhi capsules in the treatment of hyperlipidemia and the effects of it on Hs-CRP.METHODS:86 patients with hyperlipidemia were randomly divided into treatment group and control group (n=43).Treatment group were given oral dose of Siwei jiangzhi capsule and control group atorvastatin for 8 weeks.The levels of blood lipid and Hs-CRP were detected before and after medication.RESULTS:The levels of blood lipid and Hs-CRP were decreased obviously in both groups after treatment (P0.05).There was no significant difference between 2 groups(P0.05).CONCLUSION:Siwei jiangzhi capsules and Atorvastin have the same efficacy of reduing the levels of blood lipid and Hs-CRP in patients with hyperlipidemia.
Keywords:Hyperlipidemia  Siwei jiangzhi capsules  Atorvastatin  Hs-CRP
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号